Ismail Fliss

Prof. Dr. Ismail Fliss

Institute of Nutrition and Functional Foods, Universite Laval, Quebec, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
SSSamira Soltani
Samira Soltani
Riadh HammamiRiadh Hammami
Riadh Hammami
PCPaul D Cotter
Paul D Cotter
SRSylvie Rebuffat
Sylvie Rebuffat
LSLaila Ben Said
Laila Ben Said
Ismail FlissIsmail Fliss
Ismail Fliss
In recent decades, bacteriocins have received substantial attention as antimicrobial compounds. Although bacteriocins have been predominantly exploited as food preservatives, they are now receiving increased attention as potential clinical antimicrobials and as possible immune-modulating agents. Infections caused by antibiotic-resistant bacteria have been declared as a global threat to public health. Bacteriocins represent a potential solution to this worldwide threat due to their broad- or narrow-spectrum activity against antibiotic-resistant bacteria. Notably, despite their role in food safety as natural alternatives to chemical preservatives, nisin remains the only bacteriocin legally approved by regulatory agencies as a food preservative. Moreover, insufficient data on the safety and toxicity of bacteriocins represent a barrier against the more widespread use of bacteriocins by the food and medical industry. Here, we focus on the most recent trends relating to the application of bacteriocins, their toxicity and impacts.

27 January 2010 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
Riadh HammamiRiadh Hammami
Riadh Hammami
AZAbdelmajid Zouhir
Abdelmajid Zouhir
CLChristophe Le Lay
Christophe Le Lay
JHJeannette Ben Hamida
Jeannette Ben Hamida
Ismail FlissIsmail Fliss
Ismail Fliss
Background: BACTIBASE is an integrated open-access database designed for the characterization of bacterial antimicrobial peptides, commonly known as bacteriocins. Description: For its second release, BACTIBASE has been expanded and equipped with additional functions aimed at both casual and power users. The number of entries has been increased by 44% and includes data collected from published literature as well as high-throughput datasets. The database provides a manually curated annotation of bacteriocin sequences. Improvements brought to BACTIBASE include incorporation of various tools for bacteriocin analysis, such as homology search, multiple sequence alignments, Hidden Markov Models, molecular modelling and retrieval through our taxonomy Browser. Conclusion: The provided features should make BACTIBASE a useful tool in food preservation or food safety applications and could have implications for the development of new drugs for medical use. BACTIBASE is available at http://bactibase.pfba-lab-tun.org.

1 January 2012 in Frontiers in Microbiology
Verified
Journal Article
Open access
RHRima Hatoum
Rima Hatoum
SLSteve Labrie
Steve Labrie
Ismail FlissIsmail Fliss
Ismail Fliss
The yeasts constitute a large and heterogeneous group of microorganisms that are currently attracting increased attention from scientists and industry. Numerous and diverse biological activities make them promising candidates for a wide range of applications not limited to the food sector. In addition to their major contribution to flavor development in fermented foods, their antagonistic activities toward undesirable bacteria, and fungi are now widely known. These activities are associated with their competitiveness for nutrients, acidification of their growth medium, their tolerance of high concentrations of ethanol, and release of antimicrobial compounds such as antifungal killer toxins or “mycocins” and antibacterial compounds. While the design of foods containing probiotics (microorganisms that confer health benefits) has focused primarily on Lactobacillus and Bifidobacterium, the yeast Saccharomyces cerevisiae var. boulardii has long been known effective for treating gastroenteritis. In this review, the antimicrobial activities of yeasts are examined. Mechanisms underlying this antagonistic activity as well as recent applications of these biologically active yeasts in both the medical and veterinary sectors are described.

4 October 2008 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Riadh HammamiRiadh Hammami
Riadh Hammami
JHJeannette Ben Hamida
Jeannette Ben Hamida
GVGérard Vergoten
Gérard Vergoten
Ismail FlissIsmail Fliss
Ismail Fliss
Plants produce small cysteine-rich antimicrobial peptides as an innate defense against pathogens. Based on amino acid sequence homology, these peptides were classified mostly as α-defensins, thionins, lipid transfer proteins, cyclotides, snakins and hevein-like. Although many antimicrobial plant peptides are now well characterized, much information is still missing or is unavailable to potential users. The compilation of such information in one centralized resource, such as a database would therefore facilitate the study of the potential these peptide structures represent, for example, as alternatives in response to increasing antibiotic resistance or for increasing plant resistance to pathogens by genetic engineering. To achieve this goal, we developed a new database, PhytAMP, which contains valuable information on antimicrobial plant peptides, including taxonomic, microbiological and physicochemical data. Information is very easy to extract from this database and allows rapid prediction of structure/function relationships and target organisms and hence better exploitation of plant peptide biological activities in both the pharmaceutical and agricultural sectors. PhytAMP may be accessed free of charge at http://phytamp.pfba-lab.org.

2 June 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Md Ramim Tanver RahmanMd Ramim Tanver Rahman
Md Ramim Tanver Rahman
Ismail FlissIsmail Fliss
Ismail Fliss
Eric BironEric Biron
Eric Biron
The overuse and misuse of antibiotics has contributed to the rise and spread of multidrug-resistant bacteria. To address this global public health threat, many countries have restricted the use of antibiotics as growth promoters and promoted the development of alternatives to antibiotics in human and veterinary medicine and animal farming. In food-animal production, acidifiers, bacteriophages, enzymes, phytochemicals, probiotics, prebiotics, and antimicrobial peptides have shown hallmarks as alternatives to antibiotics. This review reports the current state of these alternatives as growth-promoting factors for poultry and swine production and describes their mode of action. Recent findings on their usefulness and the factors that presently hinder their broader use in animal food production are identified by SWOT (strength, weakness, opportunity, and threat) analysis. The potential for resistance development as well as co- and cross-resistance with currently used antibiotics is also discussed. Using predetermined keywords, we searched specialized databases including Scopus, Web of Science, and Google Scholar. Antibiotic resistance cannot be stopped, but its spreading can certainly be hindered or delayed with the development of more alternatives with innovative modes of action and a wise and careful use of antimicrobials in a One Health approach.

30 October 2012 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
Riadh HammamiRiadh Hammami
Riadh Hammami
BFBenoit Fernandez
Benoit Fernandez
Christophe LacroixChristophe Lacroix
Christophe Lacroix
Ismail FlissIsmail Fliss
Ismail Fliss